Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-01-24 @ 9:31 PM
Study NCT ID:
NCT05334368
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2022-04-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypereosinophilic Syndrome | View |